NiO photocathodes were fabricated by alkaline etching-anodizing nickel foil in an organic-based electrolyte. The resulting films have a highly macroporous surface structure due to rapid dissolution of the oxide layer as it is formed during the anodization process. We are able to control the films' surface structures by varying the anodization duration and voltage. With an onset potential of +0.53 V versus the reversible hydrogen electrode (RHE), the photocurrent efficiency of the NiO electrodes showed dependencies on their surface roughness factor, which determines the extent of semiconductor-electrolyte interface and the associated quality of the NiO surface sites. A maximum incident photon-to-current conversion efficiency (IPCE(max)) of 22% was obtained from NiO film with a roughness factor of 8.4. Adding an Al2O3 blocking layer minimizes surface charge recombination on the NiO and hence increased the IPCE(max) to 28%. The NiO/Al2O3 films were extremely stable during photoelectrochemical water splitting tests lasting up to 20 h, continuously producing hydrogen and oxygen in the stoichiometric 2:1 ratio. The NiO/Al2O3 and NiO films fabricated using the alkaline anodization process produced 12 and 6 times as much hydrogen, respectively, as those fabricated using commercial NiO nanoparticles.
Accumulation of perfluorobutanesulfonate (PFBS) is frequently detected in biota, raising concerns about its ecological safety. However, hazardous effects of PFBS remain largely unexplored, especially for endocrine disrupting potency. In the present study, the multigenerational endocrine disrupting potential of PFBS was investigated by exposing F0 marine medaka eggs to PFBS at different concentrations (0, 1.0, 2.9, and 9.5 μg/L) until sexual maturity. The F1 and F2 generations were reared without continued exposure. Thyroidal disturbances were examined in all three generations. PFBS exposure decreased the levels of 3,5,3'-triiodothyronine (T3) in F0 female blood; however, it increased T3 or thyroxine (T4) levels in F0 brains, in which hyperthyroidism suppressed the local transcription of 5'-deiodinase 2 ( Dio2). Obviously decreased T3 was transferred to F1 eggs, although the parental influences were reversed in F1 larvae. Delayed hatching was coupled with elevated T3 levels in F1 larvae. F1 adults showed comparable symptoms of thyroidal disruption with F0 adults. A slight recovery was noted in the F2 generation, although F2 larvae still exhibited thyroid disruption and synthesized excessive T4. Our results suggested that the offspring suffered more severe dysfunction of the thyroidal axis albeit without direct exposure. This study provided the first molecular insight about PFBS toxicology on the thyroid, beneficial to both human and environmental risk assessment.
To determine how environmental pollutants induce dysbiosis of the gut microbiota, we exposed adult zebrafish to model pollutants with varied modes of action (atrazine, estradiol, polychlorinated biphenyl [PCB]126, and PCB153) for 7 days. Subsequently, metagenomic sequencing of the intestines was performed to compare the gut microbiomes among the groups. We observed clear compound- and sex-specific responses to xenobiotic stress. Principal component analysis revealed involvement of the aryl hydrocarbon receptor (AhR) and, to a lesser extent, the estrogen receptor (ER) in the dysregulation of the intestinal microbiota. The model pollutants differentially impaired intestinal and hepatic physiological activities, as indicated by assessments of gut motility, epithelial permeability, inflammation, and oxidative stress. Correlation analysis showed that abnormal Aeromonas reproduction, especially in the PCB126 groups, was significantly positively associated with oxidative damage. Aeromonas closely interacted with Mannheimia and Blastococcus to regulate intestinal permeability. In summary, we demonstrated that ER and AhR signaling regulated the dynamics of the gut microbiota. Our findings provide new mechanistic insight into the complex interactions between the host metabolism and gut microbiota, which may contribute to the grouped assessment of environmental pollutants in future.
In
this study, marine medaka (Oryzias melastigma) were
chronically exposed for 28 days to environmentally realistic
concentrations of 4,5-dichloro-2-n-octyl-4-isothiazolin-3-one
(DCOIT) (0, 0.76, 2.45, and 9.86 μg/L), the active ingredient
in commercial antifouling agent SeaNine 211. Alterations of the hypothalamus-pituitary–gonadal-liver
(HPGL) axis were investigated across diverse levels of biological
organization to reveal the underlying mechanisms of its endocrine
disruptive effects. Gene transcription analysis showed that DCOIT
had positive regulatory effects mainly in male HPGL axis with lesser
extent in females. The stimulated steroidogenic activities resulted
in increased concentrations of steroid hormones, including estradiol
(E2), testosterone (T), and 11-KT-testosterone (11-KT),
in the plasma of both sexes, leading to an imbalance in hormone homeostasis
and increased E2/T ratio. The relatively estrogenic intracellular
environment in both sexes induced the hepatic synthesis and increased
the liver and plasma content of vitellogenin (VTG) or choriogenin.
Furthermore, parental exposure to DCOIT transgenerationally impaired
the viability of offspring, as supported by a decrease in hatching
and swimming activity. Overall, the present results elucidated the
estrogenic mechanisms along HPGL axis for the endocrine disruptive
effects of DCOIT. The reproductive impairments of DCOIT at environmentally
realistic concentrations highlights the need for more comprehensive
investigations of its potential ecological risks.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.